ClinConnect ClinConnect Logo
Search / Trial NCT06905366

Cognitive Function and Postoperative Quality of Recovery

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Mar 25, 2025

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Cognitive Function

ClinConnect Summary

This clinical trial, titled "Cognitive Function and Postoperative Quality of Recovery," is designed to explore how cognitive function (the ability to think and remember) before surgery affects how well patients recover afterward. Researchers want to understand if there is a connection between how well someone’s brain is functioning before their surgery and how smoothly their recovery goes after the procedure.

To be eligible for this study, participants need to be at least 65 years old and scheduled for elective (planned) non-cardiac surgery that lasts at least one hour. Participants will need to be able to understand the study and give their consent to participate. This trial is not yet recruiting participants, so it’s still in the planning stages. If you or a family member fits these criteria, joining this study could provide valuable insights into improving recovery experiences for older adults after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • elective non-cardiac surgery
  • age ≥65 years
  • duration of surgery ≥60 years
  • Exclusion Criteria:
  • inability to give informed consent

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported